1-2 of 2
James Herman, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Leukemias

Ivana Gojo, MD, Jan H. Beumer, PharmD, PhD, Keith Pratz, MD, Jiuping Ji, Lihua Wang, PhD, Michelle A. Rudek, PharmD, PhD, Michael A. McDevitt, MD PhD, Maria R. Baer, MD, Amanda Blackford, ScM, B. Douglas Smith, MD, Steven D. Gore, MD, Hetty E. Carraway, MD MBA, Margaret M. Showel, MD, Mark J. Levis, MD PhD, Amy E. DeZern, MD MHS, Douglas Gladstone, MD, Tania Jain, MD, Jackie Greer, RN, Marie Pouquet, PharmD, Ali-walbi Ismail, PharmD, MS, James Herman, MD, Weijie Poh, PhD, Larry Karnitz, PhD, Scott H. Kaufmann, MD PhD, Alice Chen, MD, Judith E Karp, MD
Journal: Blood
Blood (2015) 126 (23): 1361.
https://doi.org/10.1182/blood.V126.23.1361.1361
Published: 2015
Journal Articles

Combined Methyltransferase/Histone Deacetylase Inhibition with 5-Azacitidine and MS-275 in Patients with MDS, CMMoL and AML: Clinical Response, Histone Acetylation and DNA Damage.

Steven D. Gore, MD, Anchalee Jiemjit, MS, Lewis B. Silverman, MD, Timothy Aucott, Stephen Baylin, MD, Hetty Carraway, MD, Tianna Dauses, BSN, Tamer Fandy, PhD, James Herman, MD, Judith E. Karp, MD, Jonathan D. Licht, MD, Anthony J. Murgo, MD, Rosalie Odchimar-Reissig, BSN, B. Douglas Smith, MD, James A. Zwiebel, MD, Elizabeth Sugar, PhD
Journal: Blood
Blood (2006) 108 (11): 517.
https://doi.org/10.1182/blood.V108.11.517.517
Published: 2006